Brain stimulation,
Journal Year:
2024,
Volume and Issue:
17(2), P. 395 - 404
Published: March 1, 2024
BackgroundMesial
temporal
lobe
epilepsy
(MTLE)
with
hippocampal
sclerosis
(HS)
is
a
common
form
of
drug-resistant
focal
in
adults.
Treatment
for
pharmacoresistant
patients
remains
challenge,
deep
brain
stimulation
(DBS)
showing
promise
alleviating
intractable
seizures.
This
study
explores
the
efficacy
low-frequency
(LFS)
on
specific
neuronal
targets
within
entorhinal-hippocampal
circuit
mouse
model
MTLE.Objective/Hypothesis:
Our
previous
research
demonstrated
that
LFS
medial
perforant
path
(MPP)
fibers
sclerotic
hippocampus
reduced
seizures
epileptic
mice.
Here,
we
aimed
to
identify
critical
population
responsible
this
antiepileptic
effect
by
optogenetically
stimulating
presynaptic
and
postsynaptic
compartments
MPP-dentate
granule
cell
(DGC)
synapse
at
1
Hz.
We
hypothesize
can
differentially
influence
seizure
activity
depending
cellular
identity
location
or
outside
focus.MethodsWe
utilized
intrahippocampal
kainate
(ihKA)
MTLE
targeted
neural
populations
using
Channelrhodopsin2
(ChR2)
stereotactic
optic
fiber
implantation.
recorded
intracranial
from
freely
moving
chronically
mice
without
optogenetic
up
three
hours.ResultsWe
found
MPP
effectively
suppressed
epileptiform
while
principal
cells
MEC
had
no
impact.
Targeting
DGCs
septal
non-sclerotic
did
not
reduce
numbers
but
shortened
bursts.ConclusionPresynaptic
MPP-DGC
suppression
via
LFS.
World Neurosurgery,
Journal Year:
2025,
Volume and Issue:
194, P. 123621 - 123621
Published: Jan. 23, 2025
Stereotactic
neuromodulation,
such
as
deep
brain
stimulation
(DBS)
and
responsive
neurostimulation
(RNS),
have
emerged
some
of
the
more
promising
means
for
managing
drug-resistant
epilepsy.
This
study
serves
a
comprehensive
analysis
DBS
anterior
nucleus
thalamus
(ANT),
centromedian
thalamic
(CMT),
hippocampus
RNS
seizure
reduction
in
adult
intractable
Following
PRISMA
(Preferred
Reporting
Items
Systematic
Reviews
Meta-Analyses)
guidelines,
systematic
review
was
conducted
PubMed,
Cochrane
Library,
Embase
databases
from
January
2000
to
2024
objectively
assess
effectiveness
various
neuromodulation
modalities
on
reduction.
Different
software
EndNote
Rayyan
utilized
organize
1996
total
reviewed
studies
run
blinded
multi-phase
process.
A
25
were
included
with
21
166
patients
suitable
meta-analysis.
ANT,
hippocampus,
all
found
significant
individual
reductions
54.0%,
70.0%,
63.5%.
CMT
excluded
since
only
1
met
inclusion
criteria
was,
therefore,
not
Furthermore,
3
analyzed
procedures
be
when
compared
one
another.
Focal
versus
general
epilepsy
ANT
also
had
no
difference.
significantly
higher
rate
mesial
temporal
sclerosis
normal
imaging
findings.
These
results
provide
vast
amount
supporting
data
these
while
indicating
difference
between
operations.
Therefore,
this
target
population,
operative
decisions
can
made
based
surgeon
preference
patient
circumstance
without
affecting
outcomes.
Communications Biology,
Journal Year:
2025,
Volume and Issue:
8(1)
Published: Jan. 7, 2025
Intracranial
electrical
kilohertz
stimulation
has
recently
been
shown
to
achieve
similar
therapeutic
benefit
as
conventional
frequencies
around
140
Hz.
However,
it
is
unknown
how
influences
neural
activity
in
the
mammalian
brain.
Using
cellular
calcium
imaging
awake
mice,
we
demonstrate
that
intracranial
at
1
kHz
evokes
robust
responses
many
individual
neurons,
comparable
those
induced
by
40
and
Hz
both
hippocampus
sensorimotor
cortex.
The
evoked
single-cell
level
are
shaped
prominent
network
inhibition
critically
depend
on
brain
region.
At
level,
all
lead
pronounced
population
suppression
except
cortex,
which
balanced
excitatory
inhibitory
effects.
Thus,
robustly
modulates
single-neuron
levels
through
mechanisms
distinct
from
frequency
stimulation,
highlighting
clinical
potential
of
neuromodulation.
Mechanistic
study
using
reveals
neuronal
compared
neuromodulation
frequencies.
Frontiers in Psychiatry,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 30, 2025
Recent
technological
advances
in
intracranial
brain
stimulation
have
enhanced
the
potential
of
neuromodulation
for
addressing
neuropsychiatric
disorders.
We
present
a
review
methodology
and
preliminary
outcomes
pioneering
studies
exploring
biomarker
detection
closed-loop
to
modulate
high-symptom
severity
states
searched
PubMed,
Scopus,
Web
Science,
Embase,
PsycINFO/PsycNet,
followed
by
reference
citation
lists
retrieved
articles.
This
search
strategy
yielded
total
583
articles,
which
5
articles
met
inclusion
criteria,
focusing
on
depression,
obsessive-compulsive
disorder,
post-traumatic
stress
binge
eating
disorder.
discuss
identification,
biomarkers
identified,
treatment
neuromodulation.
Successful
identification
hinges
investigating
across
various
setting.
Targeted
neuromodulation,
either
directed
at
or
within
its
associated
neural
network,
offers
promising
approach.
Future
research
should
seek
understand
mechanisms
underlying
effects
as
well
long-term
viability
these
different
conditions.
Indian Pediatrics,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 7, 2025
Abstract
Epilepsy
is
a
common
and
debilitating
neurological
disorder
in
children,
approximately
third
of
them
have
ongoing
seizures
despite
adequate
trial
antiseizure
medications.
Neurostimulation
approaches
may
be
an
option
for
those
with
drug
resistant
epilepsy.
Several
invasive
non-invasive
devices
been
trialled
found
to
effective
reducing
seizure
burden
These
techniques
appear
safe
well
tolerated.
We
review
the
available
evidence
use
these
devices,
including
vagus
nerve
stimulation,
deep
brain
responsive
neurostimulation,
chronic
subthreshold
cortical
transcranial
magnetic
stimulation
direct
current
stimulation.
The
results
trials
are
promising
but
there
fewer
studies
children.
Apart
from
none
other
neurostimulation
currently
approved
children
their
off-label
or
clinical
trials.
Further
well-designed
needed,
especially
identify
most
options
optimal
parameters
improvement
quality
life.
also
being
treatment
refractory
status
epilepticus,
lack
robust
(mainly
case
series
reports)
makes
it
difficult
predict
therapeutic
benefit
at
present.
Brain,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 7, 2023
Abstract
Mesial
temporal
lobe
epilepsy
(MTLE),
the
most
common
form
of
focal
in
adults,
is
often
refractory
to
medication
and
associated
with
hippocampal
sclerosis.
Deep
brain
stimulation
represents
an
alternative
treatment
option
for
drug-resistant
patients
who
are
ineligible
resective
surgery.
In
clinical
practice,
closed-loop
at
high
frequencies
applied
interrupt
ongoing
seizures,
yet
has
(i)
a
incidence
false
detections;
(ii)
drawback
delayed
seizure-suppressive
intervention;
(iii)
limited
success
sclerotic
tissue.
As
alternative,
low-frequency
(LFS)
been
explored
recently
epilepsies.
preclinical
models,
LFS
successfully
prevented
seizures
when
continuously.
Since
it
would
be
advantageous
reduce
load,
we
developed
protocol
on-demand
LFS.
Given
importance
hippocampus
navigation
memory,
investigated
potential
consequences
on
function.
To
this
end,
used
intrahippocampal
kainate
mouse
model,
which
recapitulates
key
features
MTLE,
including
spontaneous
seizure
activity
Specifically,
our
online
detection
algorithm
monitored
epileptiform
local
field
recordings
identified
short
bursts
preceding
clusters,
triggering
stabilize
network
state.
probe
behavioural
performance,
tested
acute
influence
anxiety-like
behaviour
light-dark
box
test,
spatial
non-spatial
memory
object
location
novel
recognition
as
well
long-term
Barnes
maze.
On-demand
was
almost
effective
continuous
preventing
clusters
but
significantly
lower
load.
When
compared
performance
chronically
epileptic
mice
healthy
controls,
found
that
both
groups
were
equally
mobile,
displayed
increased
anxiety
level,
altered
learning
strategy
impaired
performance.
Most
importantly,
application
before
training
test
sessions,
could
rule
out
deleterious
effects
cognition
even
show
alleviation
deficits
recall
mice.
Taken
together,
findings
may
provide
promising
current
therapies,
overcoming
some
their
major
limitations,
inspire
further
investigation
control
syndromes.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 15, 2024
Abstract
High
frequency
anterior
nucleus
of
the
thalamus
deep
brain
stimulation
(ANT
DBS)
is
an
established
therapy
for
treatment
resistant
focal
epilepsies.
Although
high
frequency-ANT
DBS
well
tolerated,
patients
are
rarely
seizure
free
and
efficacy
other
parameters
their
impact
on
comorbidities
epilepsy
such
as
depression
memory
dysfunction
remain
unclear.
The
purpose
this
study
was
to
assess
low
vs
ANT
verbal
self-reported
anxiety
symptoms.
Five
with
temporal
lobe
were
implanted
investigational
sensing
device
capable
ambulatory
intracranial
electroencephalographic
(iEEG)
monitoring,
enabling
long-term
detection
electrographic
seizures.
While
received
therapeutic
(100
145
Hz
continuous
cycling)
(2
7
continuous)
stimulation,
they
completed
weekly
recall
tasks
thrice
self-reports
symptom
severity.
Mixed
effects
models
then
used
evaluate
associations
between
scores,
self-reports,
counts,
frequency.
Memory
score
significantly
associated
frequency,
higher
scores
during
DBS.
Self-reported
severity
not
These
findings
suggest
choice
parameter
may
patients’
cognitive
function,
independently
its
rates.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 1, 2024
ABSTRACT
The
progress
of
developing
an
effective
closed-loop
neuromodulation
system
for
many
neurological
pathologies
is
hindered
by
the
difficulties
in
accurately
capturing
a
useful
representation
brain’s
instantaneous
functional
state.
Existing
approaches
rely
on
expert
labeling
electroencephalography
data
to
develop
biomarkers
neurophysiological
pathology.
These
techniques
do
not
capture
highly
complex
states
brain
that
are
presumed
exist
between
labeled
or
allow
likely
possibility
variation
among
identically
states.
Thus,
we
propose
BrainState,
self-supervised
technique
model
arbitrarily
state
using
neural
multivariate
timeseries
data.
Application
BrainState
intracranial
from
patients
with
epilepsy
was
able
diverse
pre-seizure
and
quantify
nuanced
effects
neuromodulation.
We
anticipate
will
enable
development
sophisticated
systems
array
pathologies.